Patenteability of Biological Molecules

Authors

  • Vladimir Garcia Magalhães

Keywords:

International Property, Patent Law, Natural Biological Molecules, Biodiversity, International Law, Comparative Law, Environmental Law, Biotechnology, DNA.

Abstract

International Property Law and its branch Patent Law disposes legally new human invents with industrial application. Inventions distinguish from discoveries, due to the fact of not being pre-existent and result of human creative activity. In the USA, the USPTO – United States Patent and Trademark Office, official agency for grant of patents, allow the patent of natural biological molecules extracted and isolated from organisms, including genes and their DNA, according the assertion that these products don’t exist in pure format in their natural state, only when associated to other molecules; American Constitution and Patent Act refer to “discoveries” to allow their protection by patents. In the European Union, patent of natural molecules is established in Directive 98/44/EC, article 3.2. Munich Convention on European Patents, in article 52.2.a, however, prohibits the grant of patents for discoveries. The fact is there is not inventive activity in molecules simply isolated from nature, and is classified as discovery, not as an invention. So, this Directive conflicts with the Munich Convention, which is hierarchically higher.

Downloads

Download data is not yet available.

References

ARORA, Dilip K.; ELANDER, Richard P.; MUKERJI, K. G. Handbook of applied mycology: Fungal Biotechnology. New York: Marcel Dekker Inc., 1992. v. 4.

BERGEL, Salvador Dario. Patentes de genes; implicancias eticas y juridicas. Bioética, Brasilia, v. 5, n. 2, p. 243-52, 1997.

BURNIER, Dominique. La notion de l’invention en droit europén des brevets. Genève: Librairie Droz, 1981.

DI SABATO, Franco; LO IUDICE, Bruno. Innovazioni technologiche e diritto di empresa. 2. ed. Napoli: Morano Ed., 1982.

DOMINGUES, Douglas Gabriel. Direito Industrial e Patentes. Rio de Janeiro: Forense, 1980.

______. Privilégios de invenção, engenharia genética e biotecnologia. 1. ed. Rio de Janeiro: Forense, 1989.

ESTADOS UNIDOS da América. Department of Commerce. USPTO - United States Patent and Trademark Office. Utility Examination Guidelines. Washington: Federal Register, v. 66, n. 4, Friday, January 5, 2001. (Notices)

FRANCESCHELLI, Remo. Tratado di diritto industriale. Parte generale. Milano: Giuffre Ed., 1973. v.1.

GHIRON, Mario. Corso di diritto industriale. 2. ed. rev. e ampl. Roma: Società Editrice del “Foro Italiano”, 1937. v.2.

RAMELLA, Agostino. Trattato della proprietà industriale. v.1- le invenzione industriali. Roma: Soc. Editrice Laziale, 1909.

SILVEIRA, Newton. Curso de propriedade industrial. 2. ed. São Paulo: Ed. Revista dos Tribunais, 1987.

SOARES, José Carlos T. Biotecnologia- A mais avançada tecnologia da vida. Revista da ABPI. Rio de Janeiro, n. 10, p. 38-40, 1994.

SHIVA, Vandana [et al]. Biodiversity- social & ecological perspectives. 2. ed. London: Zed Books,1995.

VIARO, Mario. La tutela del principio scientifico nel diritto d’invenzione. Milano: Giuffrè, 1970.

WIPO- World Intellectual Property Organization. National Seminar on Innovation Promotion. Genebra, WIPO/INN/BRI/99/1, 1999.

Published

2006-01-01

Issue

Section

Não definido

How to Cite

Patenteability of Biological Molecules. (2006). Revista Da Faculdade De Direito, Universidade De São Paulo, 101, 873-900. https://www.periodicos.usp.br/rfdusp/article/view/67728